Nava H - Search Results

1

Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.

Kukar M, Alnaji RM, Jabi F, Platz TA, Attwood K, Nava H, Ben-David K, Mattson D, Salerno K, Malhotra U, Kanehira K, Gannon J, Hochwald SN. Kukar M, et al. Among authors: nava h. JAMA Surg. 2015 Jun;150(6):555-62. doi: 10.1001/jamasurg.2014.3867. JAMA Surg. 2015. PMID: 25902198

2

Pathologic Complete Response Is an Independent Predictor of Improved Survival Following Neoadjuvant Chemoradiation for Esophageal Adenocarcinoma.

Alnaji RM, Du W, Gabriel E, Singla S, Attwood K, Nava H, Malhotra U, Hochwald SN, Kukar M. Alnaji RM, et al. Among authors: nava h. J Gastrointest Surg. 2016 Sep;20(9):1541-6. doi: 10.1007/s11605-016-3177-0. Epub 2016 Jun 3. J Gastrointest Surg. 2016. PMID: 27260525

3

Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer.

Singla S, Gabriel E, Alnaji R, Du W, Attwood K, Nava H, Hochwald SN, Kukar M. Singla S, et al. Among authors: nava h. J Gastrointest Oncol. 2018 Feb;9(1):73-79. doi: 10.21037/jgo.2017.09.11. J Gastrointest Oncol. 2018. PMID: 29564173 Free PMC article.

4

Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma.

Platz TA, Nurkin SJ, Fong MK, Groman A, Flaherty L, Malhotra U, Levea CM, Yendamuri S, Warren GW, Nava HR, May KS. Platz TA, et al. J Gastrointest Oncol. 2013 Jun;4(2):137-43. doi: 10.3978/j.issn.2078-6891.2013.007. J Gastrointest Oncol. 2013. PMID: 23730509 Free PMC article.

5

Aorto-esophageal fistula: a rare fatal case caused by esophageal malignancy.

Lee RY, Flaherty L, Khushalani NI, Kanehira K, Nwogu C, Yendamuri S, Nava HR, Yang GY. Lee RY, et al. J Gastrointest Oncol. 2010 Sep;1(1):64-5. doi: 10.3978/j.issn.2078-6891.2010.006. J Gastrointest Oncol. 2010. PMID: 22811806 Free PMC article. No abstract available.

6

Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer.

Nurkin SJ, Nava HR, Yendamuri S, LeVea CM, Nwogu CE, Groman A, Wilding G, Bain AJ, Hochwald SN, Khushalani NI. Nurkin SJ, et al. Surg Endosc. 2014 Apr;28(4):1090-5. doi: 10.1007/s00464-013-3270-3. Surg Endosc. 2014. PMID: 24232046

7

Palliation of malignant dysphagia in esophageal cancer: a literature-based review.

Javle M, Ailawadhi S, Yang GY, Nwogu CE, Schiff MD, Nava HR. Javle M, et al. J Support Oncol. 2006 Sep;4(8):365-73, 379. J Support Oncol. 2006. PMID: 17004508 Review.

8

Esophageal resection for carcinoma in patients older than 70 years.

Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF. Sabel MS, et al. Ann Surg Oncol. 2002 Mar;9(2):210-4. doi: 10.1007/BF02557376. Ann Surg Oncol. 2002. PMID: 11888881

9

Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.

O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM. O'Connor BM, et al. Cancer J. 2007 Mar-Apr;13(2):119-24. doi: 10.1097/PPO.0b013e318046ee1a. Cancer J. 2007. PMID: 17476140

10

Carcinoma of the gallbladder. The Roswell Park experience.

Silk YN, Douglass HO Jr, Nava HR, Driscoll DL, Tartarian G. Silk YN, et al. Among authors: nava hr. Ann Surg. 1989 Dec;210(6):751-7. doi: 10.1097/00000658-198912000-00010. Ann Surg. 1989. PMID: 2589888 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters